Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala-Reference-Cited by-同舟云学术

Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala

Published:2023-06-26 Issue:8 Volume:28 Page:3459-3474
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Zhang Xu^ORCID,Asim Muhammad^ORCID,Fang Wei,Md Monir Hossain,Wang Huajie,Kim Kyuhee,Feng Hemin,Wang Shujie,Gao Qianqian,Lai Yuanying,He Jufang^ORCID

Funder

Innovation and Technology Fund

Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund

the following charitable foundations for their generous support to JFH: Wong Chun Hong Endowed Chair Professorship, Charlie Lee Charitable Foundation, and Fong Shu Fook Tong Foundation.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

https://www.nature.com/articles/s41380-023-02127-7.pdf

Reference87 articles.

1. Daly M, Robinson E. Depression and anxiety during COVID-19. Lancet. 2022;399:518.

2. Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin psychiatry. 2001;3:22.

3. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. Cmaj. 2003;168:1439–42.

4. Mitchell AJ. Two-week delay in onset of action of antidepressants: new evidence. Br J Psychiatry. 2006;188:105–6.

5. Hammen C. Stress and depression. Annu Rev Clin Psychol. 2005;1:293–319.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholecystokinin neurotransmission in the central nervous system: Insights into its role in health and disease;BioFactors;2024-05-22

2. Increased excitatory amino acid transporter 2 levels in basolateral amygdala astrocytes mediate chronic stress–induced anxiety-like behavior;Neural Regeneration Research;2024-04-16

3. Shedding light on cholecystokinin’s role in hippocampal neuroplasticity and memory formation;Neuroscience & Biobehavioral Reviews;2024-04

4. Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology;Molecular Neurobiology;2024-03-22

5. Netazepide, an Antagonist of Cholecystokinin Type 2 Receptor, Prevents Vincristine-Induced Sensory Neuropathy in Mice;Pharmaceuticals;2024-01-23